NCT07772011

Brief Summary

This randomized controlled clinical trial will evaluate the effect of a natural frankincense-based gel on healing of the palatal donor site after soft tissue graft harvesting. A total of 28 adult participants requiring a free gingival graft or connective tissue graft will be randomly assigned in a 1:1 ratio to one of two groups. The intervention group will receive topical frankincense gel applied to the palatal wound together with a palatal stent, while the control group will receive a palatal stent only. Participants will be followed for 30 days. The study will assess patient satisfaction, postoperative pain, wound epithelialization, wound surface area, and wound healing

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Apr 2026Mar 2027

Study Start

First participant enrolled

April 30, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 13, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Expected
Last Updated

August 19, 2026

Status Verified

August 1, 2026

Enrollment Period

1 month

First QC Date

August 13, 2026

Last Update Submit

August 17, 2026

Conditions

Keywords

FrankincenseBoswellia serrataPalatal wound healingPalatal donor siteFree gingival graftPalatal stent

Outcome Measures

Primary Outcomes (1)

  • Patient Satisfaction Scores Assessed Using a 3-Item, 7-Point Questionnaire

    Patient satisfaction will be assessed using a 3-item questionnaire evaluating willingness to undergo the same procedure again, willingness to recommend the surgical procedure to others, and overall satisfaction with the results. Each item will be rated on a 7-point scale ranging from 1 to 7, where higher scores indicate greater willingness or satisfaction. The score for each questionnaire item will be reported separately

    Day 30

Secondary Outcomes (5)

  • Pain Perception

    Days 3, 7, and 14

  • Wound Epithelialization

    Days 14, 21, and 30

  • Wound Surface Area

    up to 30 days

  • Wound Healing

    Days 3, 7, 14, 21, and 30

  • Postoperative Bleeding

    Days 3, 7, and 14

Study Arms (2)

Frankincense Gel + Palatal Stent

EXPERIMENTAL

Topical application of frankincense gel to the palatal donor site followed by placement of a palatal stent after free gingival graft harvesting.

Drug: Frankincense GelDevice: Palatal stent

Palatal Stent Only

ACTIVE COMPARATOR

Palatal stent applied to the palatal donor site after free gingival graft harvesting without frankincense gel.

Device: Palatal stent

Interventions

Topical application of a natural frankincense-based gel containing Boswellia serrata to the denuded palatal donor site after free gingival graft harvesting. The gel is applied as a continuous thin layer and followed by placement of a palatal stent.

Frankincense Gel + Palatal Stent

A palatal stent will be placed over the palatal donor site after free gingival graft harvesting to provide postoperative protection.

Frankincense Gel + Palatal StentPalatal Stent Only

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years.
  • Patients scheduled for a free gingival graft or connective tissue graft requiring a palatal donor site.
  • ASA physical status I-II

You may not qualify if:

  • Known allergy or hypersensitivity to frankincense, Boswellia species, or frankincense formulation excipients.
  • Current smoker or tobacco user.
  • Uncontrolled systemic disease, such as uncontrolled diabetes mellitus.
  • Pregnant or lactating females

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Cairo University

Cairo, Cairo Governorate, Egypt

Location

Related Publications (1)

  • Abdelrehim SMM, Elbattawy WA, Ashour OAM. The effect of nano-bio fusion gingival gel versus palatal stent on the palatal wound healing after harvesting free gingival graft: a randomized controlled clinical trial. BDJ Open. 2025 Aug 11;11(1):73. doi: 10.1038/s41405-025-00360-6.

    PMID: 40790022BACKGROUND

Study Officials

  • HAWRA FUAD ALI Mulla ALI, BDS

    Cairo University

    PRINCIPAL INVESTIGATOR
  • Dr.Manal Hosny

    Cairo University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor and statistician will be blinded to group allocation.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to two parallel groups: frankincense gel with palatal stent or palatal stent only
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master Student - Periodontology - Cairo University

Study Record Dates

First Submitted

August 13, 2026

First Posted

August 19, 2026

Study Start

April 30, 2026

Primary Completion

May 30, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

August 19, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared outside the research team. Access to the final study data will be limited to the principal investigator and study supervisors in order to maintain participant confidentiality

Locations